July 23, 2020

Artio Medical Acquires Flow Forward Medical

July 23, 2020—Artio Medical, Inc. announced it has acquired Flow Forward Medical, Inc., a medical device company developing methods for establishing and maintaining high-quality vascular access sites to improve outcomes for hemodialysis patients.

Flow Forward's Arteriovenous Fistula Eligibility system stimulates flow-mediated vein dilation to expand the initial vein diameter prior to the creation of an arteriovenous fistula (AVF). This aims to increase the number of hemodialysis patients eligible for AVF and to enhance the usability and lifespan of newly created AVFs.

“Flow Forward’s venous dilation technology is highly complementary to Artio’s existing peripheral vascular portfolio, with significant overlap in physician call points and procedures,” commented F. Nicholas Franano, President and CEO of Artio Medical, in the announcement. “This acquisition provides a unique opportunity to diversify Artio's endovascular pipeline, which will now include next-generation vascular access solutions for kidney failure patients.”

The stock-for-stock merger transaction in which Flow Forward merged with and into Artio was approved by the Board of Directors and stockholders of both companies. The transaction closed on June 8, 2020.


July 25, 2020

Analysis From Vascular Quality Initiative Show Superiority of EVAR to Open Repair for Ruptured AAA

July 22, 2020

First Patient Enrolled in Japanese Study of MedAlliance's Selution SLR Sirolimus-Eluting Balloon for PAD